Ernexa Therapeutics Inc. (ERNA) News
Track canonical SquawkNews coverage tagged to ERNA, Ernexa Therapeutics Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 5 indexed stories across 3 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
ERNA - Ernexa Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference
ERNA - Ernexa Therapeutics Participates in the Virtual Investor "Why Now" On-Demand Conference
EQUITY | Aug 27, 2026, 01:02 PM UTC
L
JTC Team Releases Virtual Investor "Why Now" On-Demand Conference Featuring Nine Public Company CEOs
JTC Team Releases Virtual Investor "Why Now" On-Demand Conference Featuring Nine Public Company CEOs
EQUITY | Aug 27, 2026, 01:01 PM UTC
H
Dow Gains Over 150 Points; Morgan Stanley Profit Tops Views
U.S. stocks traded higher this morning, with the Dow Jones gaining more than 150 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.31% to 52,670.85 while the NASDAQ rose 0.71% to 26,291.06
CENTRAL_BANK | Jul 15, 2026, 01:43 PM UTC
L
ERNA Ernexa Therapeutics - on track for ind submission Q3 2026 and phase 1 trial Q4 2026 - Plans ind submission for Q3 2026; phase 1 trial e
ERNA Ernexa Therapeutics - on track for ind submission Q3 2026 and phase 1 trial Q4 2026 - Plans ind submission for Q3 2026; phase 1 trial expected to begin Q4 2026 - Erna-101 plus anti-pd-1 achieves complete tumor clear
EQUITY | Jul 15, 2026, 11:54 AM UTC
L
ERNA Ernexa Therapeutics CEO corner highlights differentiated erna-101 platform as company advances toward planned first-in-human phase 1 st
ERNA Ernexa Therapeutics CEO corner highlights differentiated erna-101 platform as company advances toward planned first-in-human phase 1 study in 2026
EQUITY | Jul 14, 2026, 01:02 PM UTC